GSK3B and metabolic dysfunction-associated steatotic liver disease: In line with our previous findings (8), the present study found that the protein expression level of p-β-catenin/β-catenin was decreased, whereas the protein level of p-GSK3β/GSK3β was increased in the hippocampus and PFC of NAFLD rats.